Financhill
Back

Cytokinetics Quote, Financials, Valuation and Earnings

Cytokinetics Price Quote

$51.84
+0.33 (+0.64%)
(Updated: October 30, 2024 at 2:30 PM ET)

Cytokinetics Key Stats

Sell
42
Cytokinetics (CYTK) is a Sell

Day range:
$51.19 - $52.24
52-week range:
$30.68 - $110.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1,669.61
P/B ratio:
55.83%

Volume:
617.6K
Avg. volume:
1.1M
1-year change:
62.29%
Market cap:
$6.1B
Revenue:
$7.5M
EPS:
$-5.37

How Much Does Cytokinetics Make?

Is Cytokinetics Growing As A Company?

  • What Is Cytokinetics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.71%
  • What Is Cytokinetics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Cytokinetics Stock Price Performance

  • Did Cytokinetics Stock Go Up Last Month?
    Cytokinetics share price went down by -1.59% last month
  • Did CYTK's Share Price Rise Over The Last Year?
    CYTK share price rose by 62.29% over the past 1 year

What Is Cytokinetics 52-Week High & Low?

Cytokinetics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cytokinetics?

  • How Much Debt Does Cytokinetics Have?
    Total long term debt quarterly is $655M
  • How Much Cash Does Cytokinetics Have?
    Cash and short term investments quarterly total is $1.1B
  • What Is Cytokinetics’s Book Value Per Share?
    Book value per share is 0.92

Is Cytokinetics Cash Flow Positive?

  • What Is CYTK Cash Flow From Operations?
    Cash flow from operations (TTM) is -$399.1M
  • What Is Cytokinetics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.1B
  • What Is Cytokinetics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$627.3M

Cytokinetics Return On Invested Capital

  • Is Management Doing A Good Job?
    CYTK return on invested capital is -163.9%
  • What Is Cytokinetics Return On Assets?
    ROA measures how assets are converting to revenues and is -58.3%
  • What Is CYTK Return On Equity?
    ROE is a measure of profitability and is 0%

Cytokinetics Earnings Date & Stock Price

  • What Is Cytokinetics's Stock Price Today?
    A single share of CYTK can be purchased today for 51.51
  • What Is Cytokinetics’s Stock Symbol?
    Cytokinetics trades on the nasdaq under the ticker symbol: CYTK
  • When Is Cytokinetics’s Next Earnings Date?
    The next quarterly earnings date for Cytokinetics is scheduled on November 6, 2024
  • When Is CYTK's next ex-dividend date?
    Cytokinetics's next ex-dividend date is October 30, 2024
  • How To Buy Cytokinetics Stock?
    You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Cytokinetics Competitors

  • Who Are Cytokinetics's Competitors?
    Below is a list of companies who compete with Cytokinetics or are related in some way:
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Biomarin Pharmaceutical Inc (BMRN)
    • Catalyst Pharmaceuticals Inc (CPRX)
    • Ocugen Inc (OCGN)
    • Sarepta Therapeutics Inc (SRPT)

Cytokinetics Dividend Yield

Cytokinetics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -44.38%
Revenue: -71.28% -98.81%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 83.06
Upside from Last Price: 61.25%

Major Shareholders

  • How many CYTK shares are owned by institutional investors?
    222.5M CYTK shares are owned by institutional investors
  • How many CYTK shares are owned by insiders?
    2M CYTK shares are owned by insiders